title: New advancement in anthelmintic drugs in veterinary medicine.
abstract: Anthelmintic treatment of nematode infections remains the mainstay of worm control in farm and companion animals. However, control is threatened by the occurrence of drug resistant nematodes. In recent years, three new anthelmintics have been introduced to the market. Here, we describe the main features including mode of action, availability, spectrum, dose, tolerability, safety, and resistance of emodepside, monepantel, and derquantel.
authors: Novartis Animal Health, Centre de Recherche Santé Animale SA, 1566St Aubin, Switzerland. christian.epe@novartis.com
authors: Christian
authors: C
authors: Epe
authors: Ronald
authors: R
authors: Kaminsky
mesh_terms: D000818:Animals; D000871:Anthelmintics / Q000592:standards / Q000627:therapeutic use*; D004351:Drug Resistance; D009348:Nematoda; D009349:Nematode Infections / Q000188:drug therapy / Q000662:veterinary*; D014730:Veterinary Medicine / Q000639:trends*
chemical_list: D000871:Anthelmintics